Pillar 2019 Year in Review
Learn about Pillar's key wins and investment updates in 2019, including the $100 Million Pillar II Fund, and 10 new portfolio investments.
Learn about Pillar's key wins and investment updates in 2019, including the $100 Million Pillar II Fund, and 10 new portfolio investments.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Maximiz<strong>in</strong>g Health Benefits<br />
PathAI Secures $75m Series B<br />
Us<strong>in</strong>g ML to Improve Pathology<br />
Led by Co-Founders, Andy Beck and Aditya Khosla, <strong>in</strong>vestors <strong>in</strong>clude<br />
General Catalyst, General Atlantic and Merck.<br />
re:claim Health: Led by CEO,<br />
Nataly Youssef and co-founded by<br />
MIT’s Dimitrius Bertsimas, re:claim<br />
Health helps <strong>in</strong>dividuals better<br />
understand their health f<strong>in</strong>ances.<br />
Scripta: Led by CEO, Eric Lev<strong>in</strong>,<br />
Scripta analyzes your spend to help<br />
companies and consumers save up<br />
to 45% on your prescription spend.<br />
Videa Health Raises $5.4m<br />
Seed to Improve Dentistry<br />
"I just used Abridge at a cardiologist appo<strong>in</strong>tment for<br />
my husband. I loved that I could make a connection with<br />
the physician <strong>in</strong>stead of try<strong>in</strong>g to scribble everyth<strong>in</strong>g down.<br />
Be<strong>in</strong>g able to re-listen was game-chang<strong>in</strong>g for me!"<br />
Raises $4m to<br />
Help Patients<br />
Led by UPMC physician,<br />
Shiv Rao, Abridge helps<br />
patients record doctor<br />
conversations, highlight<strong>in</strong>g<br />
medical terms so you can<br />
quickly f<strong>in</strong>d diagnoses,<br />
medications, or treatments.<br />
<strong>Pillar</strong> <strong>in</strong>vested alongside<br />
Union Square Ventures.<br />
Asimov Selected by DARPA<br />
to Develop AI Design Eng<strong>in</strong>e<br />
for Synthetic Biology<br />
Led by CEO, Alec Nielsen, <strong>in</strong>vestors<br />
<strong>in</strong>clude a16z and DCVC.<br />
GRO Biosciences Leverages<br />
Synthetic Biology to Develop<br />
Best-<strong>in</strong>-Class Prote<strong>in</strong><br />
Therapeutics<br />
Catalyz<strong>in</strong>g Healthcare Innovation<br />
medium.com/pillar-companies | contact@pillar.vc |<br />
@pillar_vc<br />
19
Change language